Assessment of tissue perfusion of pancreatic cancer by means of Intravoxel incoherent motion MRI and CT perfusion: Correlation with histological microvessel density as ground truth.

Assessment of tissue perfusion of pancreatic cancer by means of Intravoxel incoherent motion MRI and CT perfusion: Correlation with histological microvessel density as ground truth. - Pancreatic Cancer-Perfusion

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022227

Enrollment

Registered

2020-06-26

Start date

2014-08-18

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C25

Interventions

Group 1: No randomization. Single-arm trial. In every study participant, the following radiological examinations are conducted on the day before planned surgery in curative intent: 1) Intravoxel incoh

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) Presence of a mass suspicious of pancreatic cancer in a previous CT and/or MRI. 2) Scheduled surgery with planned resection of the mass.

Exclusion criteria

Exclusion criteria: 1) General contraindications for the application of iodinated contrast agents. 2) MR-unsafe foreign bodies. 3) Previous treatment for pancreatic carcinoma. 4) inability to reproduce the breathing technique.

Design outcomes

Primary

Measure	Time frame
Correlation of perfusion measurements by a) IVIM DW MRI and b) CT-perfusion.	—

Secondary

Measure	Time frame
Correlation of a) perfusion measurements by imaging (IVIM DW MRI and CT perfusion) and b) histopathological microvessel density.	—

Countries

Germany

Contacts

Public ContactPhilipp Mayer

Diagnostische und Interventionelle Radiologie Universitätsklinikum Heidelberg

philipp.mayer@med.uni-heidelberg.de004962215637345

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 24, 2026